We are live on ! Find out more
VSTM icon

Verastem

94 hedge funds and large institutions have $41.7M invested in Verastem in 2019 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.46% less ownership

Funds ownership: 43.83% → 37.37% (-6.5%)

16% less funds holding

Funds holding: 112 → 94 (-18)

24% less call options, than puts

Call options by funds: $234K | Put options by funds: $307K

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

45% less capital inflows, than outflows

Capital inflows: $13M | Capital outflows: $23.7M

55% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 29

Holders
94
Holders Change
-18
Holders Change %
-16.07%
% of All Funds
2.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
24
Reduced
32
Closed
29
Calls
$234K
Puts
$307K
Net Calls
-$73K
Net Calls Change
-$312K

VSTM Hedge Fund Activity: Q2 2019 in Review

94 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in Verastem (VSTM) for Q2 2019, worth a combined $41.7M — down 57% from $95.8M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of VSTM and 13 opened new positions — a net loss of 16 holders — while 32 trimmed existing stakes and 24 added.

The largest buyer was BVF Inc, adding an estimated $5.31M. The largest seller was BlackRock, cutting an estimated $5.99M.

  • 94 institutional investors held Verastem (VSTM) as of Q2 2019, down from 112 in Q1 2019.
  • Funds reported $41.7M of Verastem stock for Q2 2019, down 57% quarter-over-quarter.
  • 13 funds opened new Verastem positions in Q2 2019 and 29 closed out, a net change of -16 holders.
  • The largest Verastem buyer in Q2 2019 was BVF Inc, an estimated $5.31M added.
  • The largest Verastem seller in Q2 2019 was BlackRock, an estimated $5.99M sold.

Based on aggregated 13F filings for Q2 2019.